Bank Of Nova Scotia Teva Pharmaceutical Industries LTD Transaction History

Bank Of Nova Scotia

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$10.67 - $14.43 $10,670 - $14,430	-1,000 Reduced 2.48%	39,346 $555,000
Q4 2023 Feb 12, 2024	SELL	$8.12 - $10.63 $148,596 - $194,529	-18,300 Reduced 31.2%	40,346 $421,000
Q3 2023 Nov 14, 2023	BUY	$7.48 - $10.7 $3,119 - $4,461	417 Added 0.72%	58,646 $598,000
Q2 2023 Aug 03, 2023	BUY	$7.2 - $9.47 $187 - $246	26 Added 0.04%	58,229 $438,000
Q4 2022 Feb 09, 2023	BUY	$7.95 - $9.48 $3,180 - $3,792	400 Added 0.69%	58,203 $530,000
Q2 2022 Aug 05, 2022	SELL	$7.38 - $10.4 $2,214 - $3,120	-300 Reduced 0.52%	57,803 $434,000
Q1 2022 May 09, 2022	BUY	$7.33 - $9.39 $19,058 - $24,414	2,600 Added 4.68%	58,103 $546,000
Q4 2021 Feb 11, 2022	SELL	$7.9 - $10.19 $4,447 - $5,736	-563 Reduced 1.0%	55,503 $443,000
Q3 2021 Nov 12, 2021	BUY	$8.38 - $10.18 $6,285 - $7,635	750 Added 1.36%	56,066 $546,000
Q2 2021 Aug 12, 2021	BUY	$9.9 - $11.56 $547,628 - $639,452	55,316 New	55,316 $548,000

624

565M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

Stay updated on Bank Of Nova Scotia with notifications on news.